Ovid Therapeutics Inc (NAS:OVID)
$ 2.69 -0.035 (-1.28%) Market Cap: 502.06 Mil Enterprise Value: 359.61 Mil PE Ratio: 0 PB Ratio: 2.27 GF Score: 48/100

Ovid Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 02:30PM GMT
Release Date Price: $2.28 (-5.79%)
Margaret Alexander
Ovid Therapeutics Inc - President, Chief Executive Officer, Director

Good morning. My name is Meg Alexander, and I'm the President and Chief Executive Officer and Director of Ovid Therapeutics Incorporated. I'm very happy to welcome you to Ovid's 2026 Annual Meeting of Stockholders. The meeting will now officially come to order. The time is now 10:30 on June 10, 2026, and the polls are now open for voting on all matters to be presented. As you know, we're hosting today's meeting for a virtual online platform hosted by Broadridge.

Before we proceed with the formal business of the meeting, I'd like to introduce you to the members of the business team who are with us here today. The officer of the company with us virtually today is Jeff Rona, our Chief Business and Financial Officer and Corporate Secretary. I'd also like to introduce you to Joseph Epstein and [Darius Monahan] of KPMG, the company's independent registered public accounting firm, who are also in attendance virtually, and they're available to respond to questions and appropriate questions as needed.

We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot